Uropathogenic Escherichia coli in Iran: Serogroup distributions, virulence factors and antimicrobial resistance properties

Annals of Clinical Microbiology and Antimicrobials

Volumn 12, Issue 1, 2013, Pages

  Momtaz, Hassan ^a   Karimian, Azam ^b   Madani, Mahboobeh ^b   Safarpoor Dehkordi, Farhad ^a   Ranjbar, Reza ^c   Sarshar, Meysam ^c   Souod, Negar ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antibiotic resistance; Escherichia coli; Serogroups; Urinary tract infections; Virulence factors

Indexed keywords

BETA LACTAM; CHLORAMPHENICOL; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE; TRIMETHOPRIM; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; HUMAN; IRAN; NONHUMAN; SEROLOGY; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENES, BACTERIAL; HUMANS; INCIDENCE; IRAN; NITROFURANTOIN; PENICILLINS; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

EID: 84876795872     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-12-8     Document Type: Article

References (70)

1. Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG. Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS One 2009, 4(3):e4752. 10.1371/journal.pone.0004752, 2649431, 19270734.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon 2003, 49(2):53-70. 10.1016/S0011-5029(03)90000-9, 12601337.
3. WHO 2005 Urinary Tract Infections in Infants and Children in Developing Countries in the Context of IMCI 2009, Switzerland: World Health Organization. Geneva, WHO 2005.
4. Struelens MJ, Denis O, Rodriguez-Villalobos H. Microbiology of nosocomial infections: progress and challenges. Microbes Infect 2004, 6(11):1043-1048. 10.1016/j.micinf.2004.05.015, 15345237.
5. Lindǐc J. Pristop k bolniku z okǔzbo sěcil. Accession to a patient with urinary tract infection. 47. Tav̌carjevi dnevi. [47th Tav̌car's days]. Zbornik prispevkov. [Proceedings] 2005, 137-148. Ljubljana, Slovenia: Medical Faculty, Fras Z, Poredǒs P, 3602003, 23496804.
6. Janke B, Dobrindt U, Hacker J, Blum-Oehler G. A subtractive hybridisation analysis of genomic differences between the uropathogenic E. coli strain 536 and the E. coli K-12 strain MG1655. FEMS Microbiol Lett 2001, 199(1):61-66. 10.1111/j.1574-6968.2001.tb10651.x, 11356568.
7. Connell H, Hedlund M, Agace W, Svanborg C. Bacterial attachment to uro-epithelial cells: mechanisms and consequences. Adv Dent Res 1997, 11(1):50-58. 10.1177/08959374970110011701, 9524442.
8. Edén CS, Hansson HA. Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infect Immun 1978, 21(1):229-237. 421981, 361565.
9. Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997, 11(3):513-529. 10.1016/S0891-5520(05)70371-8, 9378921.
10. Liu B, Knirel YA, Feng L, Perepelov AV, Senchenkova SN, Wang Q, Reeves PR, Wang L. Structure and genetics of Shigella O antigens. FEMS Microbiol Rev 2008, 32(4):627-653. 10.1111/j.1574-6976.2008.00114.x, 18422615.
11. Abe CM, Salvador FA, Falsetti IN, Vieira MA, Blanco J, Blanco JE, Blanco M, Machado AM, Elias WP, Hernandes RT, Gomes TA. Uropathogenic Escherichia coli (UPEC) strains may carry virulence properties of diarrhoeagenic E. coli. FEMS Immunol Med Microbiol 2008, 52(3):397-406. 10.1111/j.1574-695X.2008.00388.x, 18336383.
12. Ananias M, Yano T. Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 2008, 41(10):877-883. 10.1590/S0100-879X2008001000008, 19030710.
13. Bidet P, Mahjoub-Messai F, Blanco J, Blanco J, Dehem M, Aujard Y, Bingen E, Bonacorsi S. Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis. J Infect Dis 2007, 196(2):297-303. 10.1086/518897, 17570118.
14. Blanco M, Blanco JE, Alonso MP, Blanco J. Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria. Eur J Epidemiol 1996, 12(2):191-198. 10.1007/BF00145506, 8817199.
15. Johnson JR, Orskov I, Orskov F, Goullet P, Picard B, Moseley SL, Roberts PL, Stamm WE. O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. J Infect Dis 1994, 169(1):119-126. 10.1093/infdis/169.1.119, 7506278.
16. Lloyd AL, Rasko DA, Mobley HL. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol 2007, 189(9):3532-3546. 10.1128/JB.01744-06, 1855899, 17351047.
17. Orskov I, Orskov F, Birch-Andersen A, Kanamori M, Svanborg-Edén C. O, K, H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis. Scand J Infect Dis Suppl 1982, 33:18-25.
18. Yamamoto S. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother 2007, 13(2):68-73. 10.1007/s10156-007-0506-y, 17458672.
19. Donnenberg M, Welch RA. Virulence determinants of uropathogenic Escherichia coli. Urinary Tract Infections. Molecular Pathogenesis and Clinical Management 1995, 135-174. Washington, DC: American Society for Microbiology, Mobely HLT, Warren JW.
20. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991, 4(1):80-128. 358180, 1672263.
21. Soto SM, Guiral E, Bosch J, Vila J. Prevalence of the set-1B and astA genes encoding enterotoxins in uropathogenic Escherichia coli clinical isolates. Microb Pathog 2009, 47(6):305-307. 10.1016/j.micpath.2009.09.007, 19755142.
22. Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, Marrs CF. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN(E. coli). J Infect Dis 2002, 185(10):1521-1524. 10.1086/340206, 11992291.
23. Johnson JR, Russo TA, Tarr PI, Carlino U, Bilge SS, Vary JC, Stell AL. Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis. Infect Immun 2000, 68(5):3040-3047. 10.1128/IAI.68.5.3040-3047.2000, 97527, 10769012.
24. Johnson JR, Kuskowski MA, O'bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005, 49(1):26-31. 10.1128/AAC.49.1.26-31.2005, 538882, 15616271.
25. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005, 49(11):4739-4744. 10.1128/AAC.49.11.4739-4744.2005, 1280159, 16251319.
26. Oteo J, Lázaro E, de Abajo FJ, Baquero F, Campos J. Antimicrobial-resistant invasive Escherichia coli. Spain. Emerg Infect Dis 2005, 11(4):546-553.
27. Yamamoto S, Terai A, Yuri K, Kurazono H, Takeda Y, Yoshida O. Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 1995, 12(2):85-90. 10.1111/j.1574-695X.1995.tb00179.x, 8589667.
28. Le Bouguenec C, Archambaud M, Labigne A. Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 1992, 30(5):1189-1193. 265248, 1349900.
29. Tivendale K. Assessing the role of the virulence plasmid in avian pathogenic Escherichia coli 2000, University of Melbourne: B.Sc. (Hons.).
30. Struve C, Krogfelt KA. In vivo detection of Escherichia coli type 1 fimbrial expression and phase variation during experimental urinary tract infection. Microbiol 1999, 145(Pt10):2683-2690.
31. Johnson JR, Brown JJ. A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis 1996, 173(4):920-926. 10.1093/infdis/173.4.920, 8603972.
32. Kanamaru S, Kurazono H, Ishitoya S, Terai A, Habuchi T, Nakano M, Ogawa O, Yamamoto S. Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 2003, 170(6 Pt 1):2490-2493.
33. Johnson JR, O'Bryan TT, Low DA, Ling G, Delavari P, Fasching C, Russo TA, Carlino U, Stell AL. Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III. Infect Immun 2000, 68(6):3327-3336. 10.1128/IAI.68.6.3327-3336.2000, 97593, 10816481.
34. Ewers C, Janßen T, Kießling S, Philipp HC, Wieler LH. Rapid detection of virulence-associated genes in avian pathogenic Escherichia coli by multiplex polymerase chain reaction. Avian Dis 2005, 49(2):269-273. 10.1637/7293-102604R, 16094833.
35. Li D, Liu B, Chen M, Guo D, Guo X, Liu F, Feng L, Wang L. A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections. J Microbiol Methods 2010, 82(1):71-77. 10.1016/j.mimet.2010.04.008, 20434495.
36. Van TT, Chin J, Chapman T, Tran LT, Coloe PJ. Safety of raw meat and shellfish in Vietnam: an analysis of Escherichia coli isolations for antibiotic resistance and virulence genes. Int J Food Microbiol 2008, 124(3):217-223. 10.1016/j.ijfoodmicro.2008.03.029, 18457892.
37. Randall LP, Cooles SW, Osborn MK, Piddock LJ, Woodward MJ. Antibiotic resistance genes, integrons and multiple antibiotic resistance in thirty-five serotypes of Salmonella enterica isolated from humans and animals in the UK. J Antimicrob Chemother 2004, 53(2):208-216. 10.1093/jac/dkh070, 14729766.
38. Toro CS, Farfán M, Contreras I, Flores O, Navarro N, Mora GC, Prado V. Genetic analysis of antibiotic-resistance determinants in multidrug-resistant Shigella strains isolated from Chilean children. Epidemiol Infect 2005, 133(1):81-86. 10.1017/S0950268804003048, 2870225, 15724714.
39. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49(1):71-76. 10.1128/AAC.49.1.71-76.2005, 538905, 15616277.
40. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved standard-Ninth Edition (M2-A9) 2006, Wayne, PA: Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute (CLSI).
41. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001, 183(Suppl 1):S1-S4.
42. Fransson B, Lagerstedt AS, Hellmen E, Jonsson P. Bacteriological findings, blood chemistry profile and plasma endotoxin levels in bitches with pyometra or other uterine diseases. Zentralbl Veterinarmed A 1997, 44(7):417-426.
43. Dhaliwal GK, Wray C, Noakes DE. Uterine bacterial flora and uterine lesions in bitches with cystic endometrial hyperplasia (pyometra). Vet Rec 1998, 143(24):659-661.
44. Kalantar E, Motlagh M, Lornejad H, Reshadmanesh N. Prevalence of urinary tract pathogens and antimicrobial susceptibility patterns in children at hospitals in Iran. Iranian J Clin Infect Dis 2008, 3(3):149-153.
45. Esmaeili M. Antibiotics for causative microorganisms of urinary tract infections. Iranian J Pediatr 2005, 15(2):165-173. Persian.
46. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003, 88(5):444-445. 10.1136/adc.88.5.444, 1719551, 12716722.
47. Nazemi A, Mirinargasi M, Merikhi N, Sharifi SH. Distribution of pathogenic genes aatA, aap, aggR, among Uropathogenic Escherichia coli (UPEC) and their linkage with StbA gene. Indian J Microbiol 2011, 51(3):355-358. 10.1007/s12088-011-0175-5, 3209928, 22754016.
48. Ghorashi Z, Ghorashi S, Soltani-Ahari H, Nezami N. Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran. Infect Drug Resist 2011, 4:171-176. 3215345, 22114509.
49. Merçon M, Regua-Mangia AH, Teixeira LM, Irino K, Tuboi SH, Goncalves RT, Santoro-Lopes G. Urinary tract infections in renal transplant recipients: Virulence traits of Uropathogenic Escherichia coli. Transplant Proc 2010, 42(2):483-485. 10.1016/j.transproceed.2010.01.049, 20304171.
50. Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, Barbour G, Lipnick R, Cruess DF. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004, 44(2):353-362. 10.1053/j.ajkd.2004.04.040, 15264195.
51. Blahna MT, Zalewski CA, Reuer J, Kahlmeter G, Foxman B, Marrs CF. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother 2006, 57(4):666-672. 10.1093/jac/dkl020, 16464890.
52. Budde E, Naumann G, Nimmich W, Straube E. Escherichia coli O Serotyping in different patients groups with urinary tract infections (author's transl). Infection 1980, 8(1):22-26. 10.1007/BF01677394, 6989761.
53. Kausar Y, Chunchanur SK, Nadagir SD, Halesh LH, Chandrasekhar MR. Virulence factors, serotypes and antimicrobial suspectibility pattern of Escherichia coli in urinary tract infections. Al Ameen J Med Sci 2009, 2(1):47-51.
54. Arabi S, Tohidi F, Naderi S, Nazemi A, Jafarpour M, Naghshbandi R. The common fimbarie genotyping in Uropathogenic Escherichia coli. Ann Biol Res 2012, 3(10):4951-4954.
55. Asadi Karam MR, Oloomi M, Habibi M, Bouzari S. Cloning of fimH and fliC and expression of the fusion protein FimH/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran. Iranian J Microbiol 2012, 4(2):55-62.
56. Karimian A, Momtaz H, Mahbobe Madani M. Detection of uropathogenic Escherichia coli virulence factors in patients with urinary tract infections in Iran. Afr J Microbiol Res 2012, 6(39):6811-6816.
57. Nazemi A, Mirinargasi M, Khataminezhad MR, Shokouhi Mostafavi SK, Sharifi SH. Detection of stx1, stx2, LT and ST toxin genes and O157 and H7 antigen genes among uropathogenic Escherichia coli isolates from Iran. Afr J Microbiol Res 2012, 6(5):867-869.
58. Blanco M, Blanco JE, Rodriguez E, Abalia I, Alonso MP, Blanco J. Detection of virulence genes in uropathogenic Escherichia coli by polymerase chain reaction (PCR): comparison with results obtained using phenotypic methods. J Microbiol Methods 1997, 31(1-2):37-43.
59. Santo E, Macedo C, Marin JM. Virulence factors of uropathogenic Escherichia coli from a university hospital in Ribeirão Preto, São Paulo, Brazil. Rev Inst Med Trop São Paulo 2006, 48(4):185-188.
60. Takahashi A, Muratani T, Yasuda M, Takahashi S, Monden K, Ishikawa K, Kiyota H, Arakawa S, Matsumoto T, Shima H, Kurazono H, Yamamoto S. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol 2009, 47(3):791-795. 10.1128/JCM.01740-08, 2650943, 19158256.
61. Oliveira FA, Paludo KS, Arend LN, Farah SM, Pedrosa FO, Souza EM, Surek M, Picheth G, Fadel-Picheth CM. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains. Genet Mol Res 2011, 10(4):4114-4125. 10.4238/2011.October.31.5, 22057993.
62. Arslan H, Azap OK, Ergönül T, Timurkaynak F. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-adquired urinary tract infections in Turkey. J Antimicrob Chemother 2005, 56(5):914-918. 10.1093/jac/dki344, 16174685.
63. Chung A, Arianayagam M, Rashid P. Bacterial cystitis in women. Aust Fam Physician 2010, 39(5):295-298.
64. Muhammad I, Uzma M, Yasmin B, Mehmood Q, Habib B. Prevalence of antimicrobial resistance and integrons in Escherichia coli from Punjab. Pakistan. Braz J Microbiol 2011, 42(2):462-466.
65. Farshad SH, Japoni A, Hosseini M. Low distribution of integrons among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran. Polish J Microbiol 2008, 57(3):193-198.
66. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999, 281(8):736-738. 10.1001/jama.281.8.736, 10052444.
67. Kern WV, Oethinger M, Jellen-Ritter AS, Levy SB. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2000, 44(4):814-820. 10.1128/AAC.44.4.814-820.2000, 89776, 10722475.
68. Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004, 3:14. 10.1186/1476-0711-3-14, 509280, 15283864.
69. Gulsun S, Oguzoglu N, Inan A, Ceran N. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Saudi Med J 2005, 26(11):1755-1758.
70. Jadhav S, Hussain A, Devi S, Kumar A, Parveen S, Gandham N, Wieler LH, Ewers C, Ahmed N. Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India. PLoS One 2011, 6(3):e18063. 10.1371/journal.pone.0018063, 3064663, 21464963.